首页 | 本学科首页   官方微博 | 高级检索  
     


Synergy between Ficolin-2 and Pentraxin 3 Boosts Innate Immune Recognition and Complement Deposition
Authors:Ying Jie Ma  Andrea Doni  Tina Hummelsh?j  Christian Honoré   Antonio Bastone  Alberto Mantovani  Nicole M. Thielens  Peter Garred
Abstract:The long pentraxin 3 (PTX3) is a multifunctional soluble pattern recognition molecule that is crucial in innate immune protection against opportunistic fungal pathogens such as Aspergillus fumigatus. The mechanisms that mediate downstream effects of PTX3 are largely unknown. However, PTX3 interacts with C1q from the classical pathway of the complement. The ficolins are recognition molecules of the lectin complement pathway sharing structural and functional characteristics with C1q. Thus, we investigated whether the ficolins (Ficolin-1, -2, and -3) interact with PTX3 and whether the complexes are able to modulate complement activation on A. fumigatus. Ficolin-2 could be affinity-isolated from human plasma on immobilized PTX3. In binding studies, Ficolin-1 and particularly Ficolin-2 interacted with PTX3 in a calcium-independent manner. Ficolin-2, but not Ficolin-1 and Ficolin-3, bound A. fumigatus directly, but this binding was enhanced by PTX3 and vice versa. Ficolin-2-dependent complement deposition on the surface of A. fumigatus was enhanced by PTX3. A polymorphism in the FCN2 gene causing a T236M amino acid change in the fibrinogen-like binding domain of Ficolin-2, which affects the binding to GlcNAc, reduced Ficolin-2 binding to PTX3 and A. fumigatus significantly. These results demonstrate that PTX3 and Ficolin-2 may recruit each other on pathogens. The effect was alleviated by a common amino acid change in the fibrinogen-like domain of Ficolin-2. Thus, components of the humoral innate immune system, which activate different complement pathways, cooperate and amplify microbial recognition and effector functions.The ficolins are multimeric collagen-like proteins consisting of an N-terminal domain, a collagen-like domain (CD),2 and a C-terminal fibrinogen-like (FBG) domain involved in innate immune defense (1, 2). In humans, three types of ficolins have been identified as follows: Ficolin-1 (M-ficolin), Ficolin-2 (L-ficolin), and Ficolin-3 (H-ficolin/Hakata antigen). They function as recognition molecules in the lectin complement pathway along with mannose-binding lectin but with differentiated complement activating capacity (3). Ficolin-2 and Ficolin-3 circulate in the blood with a median concentration of 5 and 25 μg/ml, respectively (4, 5). Ficolin-2 is mainly produced in the liver, whereas Ficolin-3 is synthesized in both the liver and lungs, with the highest expression in the lungs (3). Ficolin-1 is primarily expressed by bone marrow-derived cells and lung epithelial cells (3, 68) and has recently been shown to be present in the blood with a median plasma concentration of 60 ng/ml (9). The ficolin genes (FCN1, -2, and -3) are polymorphic, and particularly polymorphisms in FCN2 regulate both the level and function of Ficolin-2 (4, 10, 11). In this respect, a base substitution in exon 8 at position 6359 (C→T) causing a threonine to be replaced by a methionine (T236M) in the FBG domain of Ficolin-2 has been shown to cause decreased binding activity toward GlcNAc (10).Ficolin-1 has been reported to bind to GlcNAc, GalNAc, and sialic acid (8, 12). It may opsonize Staphylococcus aureus via GlcNAc and interact with a smooth-type strain of Salmonella typhimurium through an unknown ligand, the binding of which is not diminished by GlcNAc (8). Ficolin-2 has been shown to recognize specific pathogen-associated molecular patterns, which are typically located in pathogen cell membranes, such as lipoteichoic acid and peptidoglycan in Gram-positive bacteria cell walls, lipopolysaccharide in Gram-negative bacteria cell walls, and 1,3-β-d-glucan in yeast and fungal cell walls (13, 14). The ligand specificity of Ficolin-2 has also been defined as acetyl groups, including those of N-acetylmannosamine, GlcNAc, GalNAc as well as acetyl groups on cysteine, glycine, and choline (15). Ficolin-2 recognizes clinically important pathogens, like S. typhimurium, S. aureus, and Streptococcus pneumoniae (13, 16, 17). Ficolin-3 shows affinity for GlcNAc, GalNAc, and d-fucose and may interact with S. typhimurium, Salmonella minnesota, and Aerococcus viridans (17, 18).The long pentraxin 3 (PTX3) is a soluble pattern recognition molecule mediating innate immune recognition (19). PTX3 is a glycoprotein of 45 kDa, which assembles into an octameric structure through protomer linkage by disulfide bonds (20). PTX3 shares C-terminal structural similarity with the classic short pentraxins, C-reactive protein (CRP), and serum amyloid P component, whereas the N-terminal sequence differs from the other proteins (21). Myeloid cells are a major source of PTX3, but PTX3 has also been shown in vitro to be produced by a variety of cells in response to inflammatory signals (21). During inflammation PTX3 is rapidly up-regulated and released into the surrounding tissue and into the bloodstream. PTX3 interacts with C1q and participates in activation of the classical complement pathway (22, 23). Moreover, it has also been shown that PTX3 binds the complement regulatory factor H and that this interaction regulates the alternative pathway of complement (24).PTX3 can interact with a number of different pathogens, bacteria as well as fungi and viruses. A specific binding has been observed for selected Gram-positive and Gram-negative bacteria, including S. aureus, Pseudomonas aeruginosa, S. typhimurium, Klebsiella pneumoniae, S. pneumoniae, and Neisseria meningitidis (21). PTX3 also binds zymosan and conidia from Aspergillus fumigatus) (25). Furthermore, it has been shown that ptx3 knock-out mice are extremely susceptible to invasive pulmonary aspergillosis. The phenotypic defect can be completely reversed by treatment with recombinant PTX3 (25, 26). These data indicate that PTX3 is important in protection against A. fumigatus, which has become a major cause of morbidity in medical institutions because of the increasing number of immunosuppressed patients (27).Based on the knowledge of the structural and functional similarities between C1q and the ficolins, this study was designed to characterize a possible interaction between the ficolins and PTX3 using A. fumigatus as a model. Based on our data, we propose an important role for previously unlinked collaboration of PTX3 and Ficolin-2, but not Ficolin-1 and Ficolin-3, in the recognition of A. fumigatus and amplification of complement activation. Moreover, our results demonstrate functional consequences of the Ficolin-2 T236M substitution in the interaction between PTX3 and A. fumigatus.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号